4DMedical (4DX.AX)

Overall impact
B (72)

Commentary

4DMedical is a strong overall performer. With a 'B' rating of 71.6 for overall impact (84th percentile compared to all companies), 4DMedical ranks 62nd out of 198 industry peers, behind Modular Medical, WS Audiology, Edap Tms and 58 others, and ahead of Restoration Robotics, Corindus Vascular Robotics, Medtronic and 133 others. On top material causes for 4DMedical's industry (Health Care Equipment & Supplies), 4DMedical performs well in Disease Eradication (96.0 score), Accountable Institutions (86.2), Technology Innovation (94.7) and 30 other causes where it received an 'A' score and performs poorly in Reduced Inequality (29.6 score) and Reduced Inequality (29.6).
Screens
Fur
Impact
Cause 4DX.AX
Peer rank
Overall impact

Log in to view this information

Screens
Fur
Impact trend

Change in rating for overall impact

Log in to view this information

Company
Employees
124
Sector
Health Care
Industry
Health Care Equipment & Supplies
Sub-industry
Health Care Equipment
SASB industry
Medical Equipment & Supplies
Headquarters
Vic, Australia
Share classes
4DX.AX
Description
4DMedical Limited operates as a medical technology company in the United States and Australia. It engages in the medical research technology and development of a non-invasive respiratory imaging solution using four-dimensional imaging. The company also offers X-ray velocimetry lung ventilation analysis software (XV LVAS), a lung airflow imaging software, that provides lung health detail from X-Ray scans; computed tomography lung ventilation analysis software (CT LVAS), an image processing software which operates on CT scans to provide functional lung health detail; XV Scanner, a lung function scanner; and Permetium, a multi-function imaging system for pulmonary investigations. The company was incorporated in 2012 and is based in Carlton, Australia.
Material causes
Ethos considers the following causes material for 4DMedical, based on its industry sub-industry Health Care Equipment. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.